News | ECG | August 10, 2015

ECG Screening May Predict Heart Disease Mortality for Kidney Disease Patients

Routine scans could help clinicians protect patients’ heart health

ECG screening, risk of dying, heart disease, chronic kidney disease, CKD, Rajat Deo, Perelman School of Medicine

August 10, 2015 — Several common measures obtained from electrocardiograms (ECGs) may help clinicians determine a kidney disease patient’s risk of dying from heart disease. The findings, which are published in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN), may be important for preserving kidney patients’ heart health.

ECG screening is not recommended for routinely assessing heart health in low-risk populations such as young athletes; however, would ECGs be useful in a higher-risk population such as those with chronic kidney disease (CKD), whose leading cause of death is heart disease?

To investigate, Rajat Deo, M.D., MTR, Perelman School of Medicine at the University of Pennsylvania, and his colleagues evaluated whether a panel of five common ECG parameters could enhance prediction of CKD patients’ risk of dying over a median follow-up of 7.5 years.

Among 3,587 patients in the study, 750 participants died. The researchers found that common ECG measures (PR interval, QRS duration, corrected QT interval, heart rate and left ventricular hypertrophy) identified individuals with CKD who were at an especially high risk of dying from heart disease. “By enhancing the prediction of cardiovascular death in this population, we may find more effective and novel interventions to prevent the complications of cardiovascular disease,” said Deo.

Additional research is needed to evaluate whether treating patients who are found to be at especially high risk due to ECG screening will help to improve and prolong the lives of individuals with CKD.

For more information: www.jasn.asnjournals.org


Related Content

News | Cardiac Diagnostics

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Subscribe Now